These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 24064869)

  • 21. The significance of chemical and biological warfare for the people.
    Bennett IL
    Proc Natl Acad Sci U S A; 1970 Jan; 65(1):271-9. PubMed ID: 5263757
    [No Abstract]   [Full Text] [Related]  

  • 22. Ability of physicians to diagnose and manage illness due to category A bioterrorism agents.
    Cosgrove SE; Perl TM; Song X; Sisson SD
    Arch Intern Med; 2005 Sep; 165(17):2002-6. PubMed ID: 16186470
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cutaneous manifestations of category A bioweapons.
    Aquino LL; Wu JJ
    J Am Acad Dermatol; 2011 Dec; 65(6):1213.e1-1213.e15. PubMed ID: 21777993
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Recognition and management of bioterrorism infections.
    O'Brien KK; Higdon ML; Halverson JJ
    Am Fam Physician; 2003 May; 67(9):1927-34. PubMed ID: 12751654
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Chemical and biological warfare].
    Cotrău M
    Rev Med Chir Soc Med Nat Iasi; 1990; 94(3-4):653-60. PubMed ID: 2131571
    [No Abstract]   [Full Text] [Related]  

  • 26. Cutaneous reactions in nuclear, biological and chemical warfare.
    Arora S
    Indian J Dermatol Venereol Leprol; 2005; 71(2):80-6. PubMed ID: 16394378
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Airborne exposure limits for chemical and biological warfare agents: is everything set and clear?
    Sabelnikov A; Zhukov V; Kempf CR
    Int J Environ Health Res; 2006 Aug; 16(4):241-53. PubMed ID: 16854669
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Histopathology and immunohistochemistry in the diagnosis of bioterrorism agents.
    Guarner J; Zaki SR
    J Histochem Cytochem; 2006 Jan; 54(1):3-11. PubMed ID: 16148309
    [TBL] [Abstract][Full Text] [Related]  

  • 29. CDC issues guidelines on illnesses associated with intentional release of biologic agents.
    Ressel G;
    Am Fam Physician; 2001 Nov; 64(10):1761-2, 1764. PubMed ID: 11759081
    [No Abstract]   [Full Text] [Related]  

  • 30. Bioterrorism in the United States: take it seriously.
    Chaffee M; Conway-Welch C; Stephens V
    Am J Nurs; 2001 Nov; 101(11):59, 61. PubMed ID: 11718117
    [No Abstract]   [Full Text] [Related]  

  • 31. Chemical warfare agents.
    Kuca K; Pohanka M
    EXS; 2010; 100():543-58. PubMed ID: 20358695
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Anthrax, botulism and tularemia in Italy.
    Serraino D; Puro V; Bidoli E; Piselli P; Girardi E; Ippolito G
    Infection; 2003 Mar; 31(2):128-9. PubMed ID: 12749299
    [No Abstract]   [Full Text] [Related]  

  • 33. Weapons of mass destruction: the decontamination of children.
    Rotenberg JS; Burklow TR; Selanikio JS
    Pediatr Ann; 2003 Apr; 32(4):260-7. PubMed ID: 12723121
    [No Abstract]   [Full Text] [Related]  

  • 34. Antidotes and treatments for chemical warfare/terrorism agents: an evidence-based review.
    Rodgers GC; Condurache CT
    Clin Pharmacol Ther; 2010 Sep; 88(3):318-27. PubMed ID: 20686476
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Methemoglobinemia in patients attacked by chemical and microbiological warfare agents.
    Heyndrickx A; Van Steenberge M
    Arch Belg; 1984; Suppl():69-73. PubMed ID: 6535499
    [No Abstract]   [Full Text] [Related]  

  • 36. The challenge of biological and chemical weapons.
    Meselson M
    Bull World Health Organ; 1999; 77(2):102-3. PubMed ID: 10083706
    [No Abstract]   [Full Text] [Related]  

  • 37. Pharmacy preparedness for incidents involving weapons of mass destruction.
    Burda AM; Sigg T
    Am J Health Syst Pharm; 2001 Dec; 58(23):2274-84. PubMed ID: 11763806
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The USA preparing for bioterrorism: the role of Fort Detrick since 1970.
    Proctor RA
    WMJ; 2002; 101(2):20-4. PubMed ID: 12085492
    [No Abstract]   [Full Text] [Related]  

  • 39. [Gene warfare].
    Mäkelä PH
    Duodecim; 1993; 109(23-24):2184-6. PubMed ID: 7743971
    [No Abstract]   [Full Text] [Related]  

  • 40. New aspects in mass casualties.
    Anasthesiol Intensivmed Notfallmed Schmerzther; 2002 Sep; 37(9):537-8. PubMed ID: 12215939
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.